IDH2 and central nervous system cancer: In this study, we prospectively analyzed the clinical utility of SVS and 1H-MRSI using an optimized TE (97 ms) in assessing IDH-mutational status by detecting the characteristic resonances of 2HG in patients presenting with newly diagnosed infiltrative gliomas and suspected neoplastic progression.